Navigation Links
Cancer Cell article shows first evidence for targeting of Pol I as new approach to cancer therapy
Date:7/10/2012

The Cancer Cell publication highlighted a number of potential competitive advantages of CX-5461. An unanticipated finding was that malignant cells are considerably more dependent upon maintenance of high levels of Pol I activity than previously believed, and even modest inhibition of Pol I triggers cancer cell death. These results suggest that selective activation of a surveillance pathway to activate p53, using Pol I inhibitors such as CX-5641, is likely to be therapeutically useful in the treatment of a wide range of tumors. In addition, as a cancer-specific inducer of p53, CX-5461 was shown to be 300 times more potent than currently studied non-genotoxic p53 activators with alternate mechanisms.


'/>"/>

Contact: Joleen Schultz
jschultz@mentus.com
760-271-8150
Cylene Pharmaceuticals
Source:Eurekalert

Page: 1 2

Related biology news :

1. Researchers discover molecule in immune system that could help treat dangerous skin cancer
2. Stanford scientists find molecule to starve lung cancer and improve ventilator recovery
3. Tumor microenvironment helps skin cancer cells resist drug treatment
4. Cancer scientists link ‘oncometabolite’ to onset of acute myeloid leukemia
5. The genomics symposium to boost the further development of cancer research
6. Study identifies pathway to enhance usefulness of EGFR inhibitors in lung cancer treatment
7. Regulation of telomerase in stem cells and cancer cells
8. 5th Latin American Conference on Lung Cancer
9. Husband-wife team set out to improve breast cancer exams
10. Double the pain: RUB biologists find the cause of pain in the treatment of fair skin cancer
11. A new indicator for breast cancer relapse identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... SAN JOSE, Calif. , July 27, 2015 ... leading developer of human interface solutions, today announced ... ClearPad ® touchscreen solution for its stylish ... controller for its proven reliability, low power and ... with a wet finger. Huawei designers also required ...
(Date:7/27/2015)... , July 27, 2015   Zynx ... and experience-based clinical improvement solutions, today announced that ... is now available on Android smartphones and tablets. ... and post-care organizations can use ZynxCarebook to securely ... patient,s condition, streamline care transitions to other care ...
(Date:7/23/2015)... Aware, Inc. (NASDAQ: AWRE ), a leading supplier of ... second quarter ended June 30, 2015.  Revenue ... decrease of 33% compared to $6.8 million in the same ... 2015 was $0.3 million, or $0.01 per diluted share, which ... the same period a year ago.  Lower ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
... Chicago have been awarded more than $12 million by the ... acquired and familial causes of heart failure -- with the ... The five years of new funding supports an ongoing ... and head of physiology and biophysics at UIC, that looks ...
... Oil and water don,t mix, but add in some ... team of UCLA chemists and engineers has developed a new ... are both transparent and electrically conductive. Their method involves the ... this solution is sufficiently agitated it spreads over virtually any ...
... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ... financial results on Wednesday, November 10, 2010 after the markets close. ... p.m. Eastern Time to discuss the financial results.   ... conference call via phone, please dial (866) 271-5140 from the United ...
Cached Biology News:$12 million grant to probe root causes of heart failure 2Radically simple technique developed to grow conducting polymer thin films 2Radically simple technique developed to grow conducting polymer thin films 3PDL BioPharma to Announce Third Quarter 2010 Financial Results on November 10, 2010 2
(Date:7/27/2015)... July 27, 2015  Amgen (NASDAQ: AMGN ) ... financial results on Thursday, July 30, 2015, after the ... be followed by a conference call with the investment ... from Amgen will be Robert A. Bradway , ... Amgen,s senior management team. Live audio of ...
(Date:7/27/2015)... and FRANKLIN, Tenn. , July ... premier provider of health care services and one ... U.S., today announced that its parent company and ... definitive agreement with Medical Properties Trust, Inc. ("MPT") ... Capella for $900 million in cash.  The transaction is expected ...
(Date:7/27/2015)... , July 27, 2015 /PRNewswire/ - Quest PharmaTech ... company developing and commercializing products for the treatment of ... Quest announces that it has closed a $1,000,000 unit ... placement of 16,666,667 units of the Company at a ... of one common share and one common share purchase ...
(Date:7/27/2015)... ... July 27, 2015 , ... This ... industry.The report provides a basic overview of the industry including definitions, classifications, applications ... markets including development trends, competitive landscape analysis, and key regions development status. Development ...
Breaking Biology Technology:Amgen Announces Webcast of 2015 Second Quarter Financial Results 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 5Quest PharmaTech Closes $1,000,000 Private Placement 22015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3
... Catalyst,Pharmaceutical Partners, Inc. (Nasdaq: CPRX ) today ... months ended June 30, 2008., "We continue ... stated Patrick J. McEnany, Catalyst,s Chief Executive Officer.,"In ... in our U.S.,Phase II clinical trials evaluating CPP-109 ...
... TAIAN CITY, Shandong, China, Aug. 14 /Xinhua-PRNewswire-FirstCall/ --,China ... Biologic,",the "Company"), one of the leading plasma-based pharmaceutical ... reported financial results,for the second quarter ended June ... -- Revenues increased 35.1% year-over-year to $11.9 ...
... 14 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC Bulletin Board: CHBT) ... the manufacture,research, development, marketing and distribution of probiotics ... quarter of its 2009,fiscal year, ended June 30, ... -- Net sales increased 19.5% year-over-year to $11.4 ...
Cached Biology Technology:Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results 2Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results 3Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results 4Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results 5China Biologic Products Reports Second Quarter 2008 Results 2China Biologic Products Reports Second Quarter 2008 Results 3China Biologic Products Reports Second Quarter 2008 Results 4China Biologic Products Reports Second Quarter 2008 Results 5China Biologic Products Reports Second Quarter 2008 Results 6China Biologic Products Reports Second Quarter 2008 Results 7China Biologic Products Reports Second Quarter 2008 Results 8China Biologic Products Reports Second Quarter 2008 Results 9China Biologic Products Reports Second Quarter 2008 Results 10China Biologic Products Reports Second Quarter 2008 Results 11China Biologic Products Reports Second Quarter 2008 Results 12China Biologic Products Reports Second Quarter 2008 Results 13China Biologic Products Reports Second Quarter 2008 Results 14China Biologic Products Reports Second Quarter 2008 Results 15China-Biotics, Inc. Reports First Quarter 2009 Financial Results 2China-Biotics, Inc. Reports First Quarter 2009 Financial Results 3China-Biotics, Inc. Reports First Quarter 2009 Financial Results 4China-Biotics, Inc. Reports First Quarter 2009 Financial Results 5China-Biotics, Inc. Reports First Quarter 2009 Financial Results 6China-Biotics, Inc. Reports First Quarter 2009 Financial Results 7China-Biotics, Inc. Reports First Quarter 2009 Financial Results 8China-Biotics, Inc. Reports First Quarter 2009 Financial Results 9China-Biotics, Inc. Reports First Quarter 2009 Financial Results 10China-Biotics, Inc. Reports First Quarter 2009 Financial Results 11
... system uses three Adept CE 4100 high pressure ... in one microlitre increaments. The Adept CE ... System control and data processing is provided by ... 4900., Column heater/chillers can be supplied. ...
... The excellent isocratic refractive index chromatography system, ... CE 4700. Data processing is provided ... delivery is by the high pressure CE 4100 ... can be supplied. The system can ...
Narrow-mouth has heavy-duty rim. Approximate graduations are in durable white enamel. Extra large marking space. capacity 125 mL Special grade: student grade...
...
Biology Products: